$AME

AMETEK (AME) Q2 2026 Earnings Call Transcript

AMETEK (AME) reported Q2 2026 net sales of $2.04B, up 15% year over year, with 10% organic growth. Adjusted EPS was $2.09, up 17%, above guidance of $1.96 to $2.00. Total orders were $2.3B, up 28%, backlog $4.11B. Full-year sales guidance rose about 10% and adjusted EPS to $8.20-$8.30.

Original reporting
Published Aug 11, 2026, 5:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 5:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMETEK (AME) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AMEBullishHigh
01

Why it matters

The combination of higher sales and EPS guidance, record orders/backlog, and improved working capital conversion provides a coherent upside earnings narrative for AMETEK.

02

Market read

Traders can use the raised FY and Q3 adjusted EPS ranges, record orders/book-to-bill, and margin and cash-flow improvements to reassess near-term earnings expectations.

03

What to watch

The text highlights a large acquisition and credit facility renewal, but does not quantify integration risks, customer concentration, or potential margin pressure from input costs.

Relevance 9/10Novelty 9/10Timing: post-earnings call, guidance and capital/credit updates for immediate repricing

Background

AMETEK’s Q2 2026 earnings call covers record orders, margin expansion, free cash flow, and updated full-year guidance plus acquisition and financing updates.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK reported Q2 2026 net sales of $2.04B, adjusted EPS $2.09, and raised full-year sales and EPS guidance.

Expected impact

Bullish bias for near-term trading as raised FY and Q3 EPS ranges confirm demand and margin momentum.

Evidence & confidence

The article discloses multiple decision-relevant datapoints: raised FY sales and adjusted EPS guidance, Q3 EPS guidance, record orders/book-to-bill, and margin and free-cash-flow expansion.

Market effects

Signals continued strength in industrial instrumentation and electronics tied to AI infrastructure, semiconductors, and defense modernization demand.

No specific regional demand signal beyond broad-based growth across AMETEK divisions.

Demand drivers cited (semiconductor manufacturing, hyperscaler data centers, defense modernization) are globally distributed end markets.

Counterpoint

Raised guidance could already be partially priced; investors may focus on acquisition integration and whether synergy assumptions (Indicor) are achievable.

Key entities

  • AMETEK, Inc.

    Reported Q2 2026 results and raised full-year sales and adjusted EPS guidance; discussed Indicor acquisition, margins, and credit facility renewal.

  • Indicor Instrumentation

    Planned acquisition expected to close in the second half of 2026, with management citing cost synergies.

  • Zygo

    AMETEK metrology and optical solutions business referenced as a semiconductor manufacturing growth driver.

  • RTDS Technologies

    AMETEK unit referenced as receiving an order from a data center hyperscaler for real-time digital simulation.

Related articles

$AMEMedAI 9/10

AMETEK’s (AME) $5B Deal Bets Big On A Hot Streak

AMETEK (AME) completed a $5.0B cash acquisition of Indicor Instrumentation. The company reported record Q2 sales of $2.04B, up 15% YoY, and raised full-year guidance. Indicor is expected to add $350M to 2026 sales and be modestly accretive to earnings. The deal aligns with AMETEK's existing portfolio and markets.

$RIMEMed

Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75

Carets Corp is exploring a potential sale, including its technology and patents. Algorhythm Holdings (RIME) and Biomerica (BMRA) are evaluating strategic alternatives. nVent Electric (NVT) acquired Maverick Power for $1.75B, with up to $550M more in performance-based payments. Descartes (DSGX) bought Tai for $100M, and Navitas (NVTS) acquired Claros for up to $232.8M. Booz Allen (BAH) completed a $720M acquisition, and Elastic (ESTC) acquired Deductive AI. BioXcel (BTAI) filed for Chapter 11 ban

$AMEHighAI 9/10

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

$AMEHighAI 9/10

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.